Cargando…
Treatment of lupus erythematosus with fumaric acid ester derivatives: two case-reports
Autores principales: | Balak, Deepak MW, Thio, H Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242241/ http://dx.doi.org/10.1186/1479-5876-9-S2-P15 |
Ejemplares similares
-
Fumaric acid esters in the management of psoriasis
por: Balak, Deepak MW
Publicado: (2015) -
Drug-induced Fanconi syndrome associated with fumaric acid esters treatment for psoriasis: a case series
por: Balak, Deepak M.W., et al.
Publicado: (2016) -
Cutaneous adverse events associated with long-term immunomodulating therapy in multiple sclerosis
por: Balak, Deepak MW, et al.
Publicado: (2011) -
In vitro pharmacokinetics of anti-psoriatic fumaric acid esters
por: Litjens, Nicolle HR, et al.
Publicado: (2004) -
PReS-FINAL-2356: A comparison of the American college of rheumatology and the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus using data from the uk juvenile systemic lupus erythematosus cohort study
por: Lloyd, O, et al.
Publicado: (2013)